What factor has been shown to predict the greatest benefit from continuous glucose monitor use in type 1 diabetes patients?

The frequency of sensor use is a critical factor that predicts the greatest benefit from continuous glucose monitor (CGM) use in patients with type 1 diabetes. Research indicates that greater adherence to using the CGM results in improved glycemic control, as it allows patients to obtain real-time glucose readings, track trends, and make informed decisions regarding their insulin administration and lifestyle choices.

When patients consistently use the CGM, they are more likely to respond proactively to fluctuations in glucose levels, which can lead to a more stable overall blood glucose profile and a reduction in the incidence of hypoglycemic or hyperglycemic episodes. This consistent data provides actionable insights that empower patients to adjust their behaviors and treatment plans, significantly improving their management of diabetes over time.

In contrast, factors such as patient age, duration of diabetes, and type of insulin therapy may contribute to overall diabetes management but do not specifically align with the direct impact of CGM use frequency on patient outcomes. For instance, a younger patient may benefit from CGM but if they do not use it frequently, the anticipated improvements in glycemic control may not be realized to the same extent. Similarly, whether a patient has had diabetes for a shorter or longer time, or the type of insulin therapy they are using